Clinical Care Delivery in Chest Pain Patients Without an Acute Coronary Syndrome—A Retrospective Cohort Study
Abstract
Background: Chest pain is a prevalent and critical complaint among patients in emergency departments (EDs) across the United States. Professional societies have refined clinical guidelines to establish the most effective diagnostic pathways for identifying obstructive coronary artery disease. However, many healthcare systems do not adhere to the guideline-validated clinical pathways and instead order repeat diagnostic testing. This study evaluated the efficiency of care delivered to chest pain patients in our tertiary medical center. Methods: We performed a retrospective chart review of patients presenting to our ED with acute chest pain between November and December 2022, collecting information about chest pain, the testing received, and their outcomes. The data were then reviewed to determine clinical practice patterns. Results: We included 342 patients, with a mean age of 54 years; 54.7% of study participants were females. Patients who were eventually admitted from the ED (46.5%, n = 159) were either under observation or inpatient status. Furthermore, 16.6%, n = 57, of patients had an ischemic evaluation within the preceding year. Physicians documented a HEART score in 24.6%, n = 84 of the patients. While HEART score is a considerable factor utilized by admitting physicians to triage incoming patients, 39%, n = 62, of all admitted patients had a low HEART score (<3) and a negative ischemic evaluation within the past year. Conclusions: This single-center retrospective…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.